Development of a Computer-aided Polypectomy Decision Support

Sponsor
Centre hospitalier de l'Université de Montréal (CHUM) (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04811937
Collaborator
(none)
605
1
1
24
25.2

Study Details

Study Description

Brief Summary

Quality components of colonoscopy include the detection and complete removal of colorectal polyps, which are precursors to CRC. However, endoscopic ablation may be incomplete, posing a risk for the development of "interval cancers". The investigator propose to develop a solution based on artificial intelligence (AI) (CADp computer-aided decision support polypectomy) to solve this problem.This research project aims to develop CADp, a computer decision support solution (CDS) for the ablation of colorectal polyps from 1 to 20 mm.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Computer-aided polypectomy decision support by Artificial Intelligence
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
605 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
prospective, multi-endoscopist, single center, clinical study at tertiary referral center (CHUM)prospective, multi-endoscopist, single center, clinical study at tertiary referral center (CHUM)
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Development of a Computer-aided Polypectomy Decision Support
Anticipated Study Start Date :
Apr 1, 2021
Anticipated Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Artificial intelligence for real-time Computer decision support of resection of colorectal polyps

A standard colonoscopy will be performed according to the standard of routine care. All optically diagnosed polyps will be removed and sent to the CHUM pathology laboratory for histopathological evaluation according to institutional standards. The AI system will capture video of the procedure in real time, and provide additional information about polypectomy procedures.

Diagnostic Test: Computer-aided polypectomy decision support by Artificial Intelligence
The AI system will capture the live video of the procedure and the AI feedbackwill be shown on a second screen installed next to the regular endoscopy screen. Screen A will show the regular endoscopy image and screen B will show the regular endoscopy image together with the areas that might harbor a polyp and the information to help the polypectomy.

Outcome Measures

Primary Outcome Measures

  1. Accuracy of the CADp system [3 weeks]

    accuracy with which the CADp system predicts completeness of polypectomy in the test set with the reference standard for completeness being determined by the histology of post-polypectomy margin biopsies; if free from any polyp tissue (adenomatous, serrated or hyperplastic), the resection will be considered complete. If remnant polyp tissue is detected in any one or more of the margin biopsies the resection is deemed incomplete

  2. Completeness of polypectomy [1 month]

    We will evaluate the agreement between the different subjective and objective ways of assessing the completeness of the polypectomy : evaluation of margins (presence or not, measurement of margins) by endoscopists self-assessment, and by expert consensus.

  3. Training CADp [1 month]

    Evaluation of the concordance of data on polyp size, extension of margins around the polyp, quality of resection between clinical data (endoscopists' self-assessment and experts' assessments) and CADp prediction.

  4. Validity of the choice of primary outcome [1 month]

    Based on the results and comparison of the different assessment methods, we will perform sensitivity analyses to assess the validity and robustness of the choice of primary outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Signed informed consent

  • Age 45-80 years

  • Indication to undergo a lower GI endoscopy.

Exclusion Criteria:
  • Known inflammatory bowel disease

  • Active colitis

  • Coagulopathy

  • Familial polyposis syndrome;

  • Poor general health, defined as an American Society of Anesthesiologists (ASA) physical status class >3

  • Emergency colonoscopies

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier Universitaire de Montréal Montréal Quebec Canada

Sponsors and Collaborators

  • Centre hospitalier de l'Université de Montréal (CHUM)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre hospitalier de l'Université de Montréal (CHUM)
ClinicalTrials.gov Identifier:
NCT04811937
Other Study ID Numbers:
  • 20.382
First Posted:
Mar 23, 2021
Last Update Posted:
Mar 23, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre hospitalier de l'Université de Montréal (CHUM)
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 23, 2021